Avoro Capital Advisors LLC

Q2 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2024
Date filed
8/14/2024
Form type
13F-HR
Num holdings
41
Total value ($000)
$7,508,400
Net value change ($000)
-1,065,113 (-12.4%)
New positions
3
Sold out positions
8
Turnover %
10.6%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2024 Next filing: 11/14/2024 SEC filing

Snapshot: Change Analysis

Compared to Q1 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
UTHR 253,955 38.7%
RNAM 117,075 78.8%
MDGL 56,640 10.9%
ALNY 52,365 116.8%
ARGX 44,981 9.2%
Merus N.V. 40,148 100.3%
Intra-Cellular Therapies, Inc. 34,200 20.0%
SLNO 15,790 22.7%
BCYC 14,168 NEW
BCRX 11,389 17.2%
Top Reduces (Value $000, Stocks/ETFs)
VKTX -294,380 -100.0%
ALPINE IMMUNE SCIENCES, INC. -228,921 -100.0%
APLS -226,889 -34.7%
XBI -126,652 -31.0%
MGNX -90,528 -100.0%
SRPT -88,432 -15.7%
IOVA -79,560 -45.9%
VERA -71,106 -31.3%
FOLD -50,964 -15.8%
ROIV -49,023 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type